Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome

Area of Science:

• Cardiovascular Biology
• Cell Biology
• Pathophysiology

Background:

• Microparticles are vesicles released during cell activation and apoptosis.
• Elevated microparticle levels are observed in cardiovascular diseases.
• The specific link between circulating microparticles and endothelial dysfunction remains unclear.

Purpose of the Study:

• To characterize circulating microparticles in metabolic syndrome (MS) patients.
• To evaluate the impact of MS-derived microparticles on endothelial function.

Main Methods:

• Flow cytometry was used to analyze microparticle origins in blood samples from MS patients and healthy controls.
• In vitro studies involved treating human endothelial cells with MS microparticles.
• In vivo studies assessed endothelium function in mice following intravenous injection of MS microparticles.

Main Results:

• MS patients exhibited higher levels of circulating microparticles from platelet, endothelial, erythrocyte, and procoagulant sources.
• In vitro, MS microparticles reduced nitric oxide and superoxide anion production in endothelial cells.
• In vivo, MS microparticles impaired endothelium-dependent relaxation and decreased endothelial nitric oxide synthase expression in mice.

Conclusions:

• Circulating microparticles from MS patients contribute to endothelial dysfunction.
• These microparticles alter nitric oxide bioavailability and vascular reactivity.
• Findings suggest microparticles are key players in the pathophysiology of MS-related cardiovascular complications.